Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is NRXN1 Gene Expression an Important Marker of Treatment of Depressive Disorders? A Pilot Study

6 Jul 2021

Abstract excerpt

Aim: Due to the fact that NRXN1 is associated with neurodevelopmental disorders, the aim of this study was to investigate the role of the NRXN1 gene in the etiology and epigenetics of depression by comparison of NRXN1 mRNA expression and NRXN1 protein level expression in patients suffering from depression versus healthy controls, as well as to search for clinical variables related to expression of the analyzed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetics and Neurodevelopmental Disorders
Share to Health, Environment, Cognitive Aging
Share to Science, Research, and Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34357104
DOI: 10.3390/jpm11070637

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is NRXN1 Gene Expression an Important Marker of Treatment of Depressive Disorders? A Pilot StudyPMID 34357104Read ↗

Integrative bioinformatics and artificial intelligence analyses of transcriptomics data identified genes associated with major depressive disorders including NRG1Semantic proximity Read ↗

Circulating NEGR1 Protein Levels Associate with Symptom Severity in Drug-Naïve Major Depressive DisorderSemantic proximity Read ↗

Neurobiology of depression and novel antidepressant drug targets.Semantic proximity Read ↗

NEGR1 can influence symptom severity in fluoxetine treated major depression disorder patientsSemantic proximity Read ↗

Integrative Mouse and Human mRNA Studies Using WGCNA Nominates Novel Candidate Genes Involved in the Pathogenesis of Major Depressive DisorderSemantic proximity Read ↗

Integrating genome-wide association study and expression quantitative trait loci data identifies NEGR1 as a causal risk gene of major depression disorder.Semantic proximity Read ↗

Effective biomarkers and therapeutic targets of nerve-immunity interaction in the treatment of depression: an integrated investigation of the miRNA-mRNA regulatory networksSemantic proximity Read ↗

Are there meaningful biomarkers of treatment response for depression?Semantic proximity Read ↗

Intron retention as an excellent marker for diagnosing depression and for discovering new potential pathways for drug interventionSemantic proximity Read ↗

Transcriptional profiling of antidepressant ketamine and electroconvulsive therapy treatmentSemantic proximity Read ↗

Altered mRNA expressions for N-methyl-D-aspartate receptor-related genes in WBC of patients with major depressive disorderSemantic proximity Read ↗

Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key PathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.